INTEGRATING AYURGENOMICS WITH POLYCYSTIC OVARY SYNDROME: A SCOPING REVIEW OF METABOLIC PHENOTYPES (PRAKRITI) AND PERSONALIZED MANAGEMENT IN STREE ROGA

Main Article Content

Dr. Hemant Kuma
Dr. Ankita Chouhan
Dr.Varsha

Keywords

PCOS, Ayurgenomics, Prakriti, Artava Kshaya, Stree Roga, Personalized Medicine, Metabolic Phenotypes, Tridosha, Shodhana, Genomics.

Abstract

Polycystic Ovary Syndrome (PCOS) is a complex, multi-systemic endocrine and metabolic disorder affecting women of reproductive age, characterized by clinical or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Despite significant advancements in modern endocrinology, the management of PCOS remains largely symptomatic, often failing to address the profound inter-individual variability in metabolic profiles and therapeutic responses. This research paper explores the integration of "Ayurgenomics"—an innovative trans-disciplinary field merging the ancient Ayurvedic science of Prakriti (individual constitution) with modern genomic and "omics" technologies—to provide a personalized framework for the management of PCOS within the domain of Stree Roga (Ayurvedic Gynecology).


Through a comprehensive scoping review adhering to PRISMA-ScR guidelines, this study identifies the molecular basis of the three primary Prakriti types (Vata, Pitta, and Kapha) and correlates them with the four modern PCOS phenotypes (Phenotypes A, B, C, and D). Evidence indicates that Kapha-dominant individuals exhibit a genetic predisposition toward obesity and metabolic syndrome, often involving polymorphisms in the FTO and CYP2C19 genes, whereas Pitta-dominant types demonstrate heightened inflammatory responses and specific metabolic efficiencies. The paper elucidates the Ayurvedic pathophysiology of PCOS, primarily through the lens of Artava Kshaya, Pushpagni Jataharini, and Sroto-avarodha, emphasizing the disruption of the HPO axis as a manifestation of Vata-Kapha imbalance.[i]


The review synthesizes personalized management strategies, contrasting conventional pharmacological interventions like Metformin with Ayurvedic Shodhana (purificatory) protocols such as Virechana and Basti, and Shamana (palliative) herbal formulations. By mapping the "genotype-phenotype" nexus, this study provides a scientific rationale for tailored interventions in Stree Roga, suggesting that Ayurgenomics can transform PCOS management from a reactive symptom-based model to a predictive and personalized preventive paradigm.


 


 

Abstract 0 | Pdf Downloads 0

References

1. Acharya, J. T. (Ed.). (2008). Sushruta Samhita of Sushruta with the Nibandhasangraha Commentary of Shri Dalhanacharya (Sharira Sthana, Chapter 3, Shloka 10, p. 346). Varanasi: Chaukhamba Krishnadas Academy..
2. Prasher, B., Negi, S., Aggarwal, S., Mandal, A. K., Sethi, T. P., Deshmukh, S. R.,... & Mukerji, M. (2008). Whole genome expression and biochemical correlates of extreme constitutional types defined in Ayurveda. Journal of Translational Medicine, 6, 48. DOI: 10.1186/1479-5876-6-48..
3. Vaidya, H. P. (Ed.). (2006). Ashtanga Hridayam of Vagbhata with Sarvangasundra of Arunadatta & Ayurvedarasayana of Hemadri (Sharira Sthana, Chapter 1, Shloka 11, p. 364). Varanasi: Chaukhamba Krishnadas Academy..
4. Rajput, S., et al. (2024). Clinical assessment of the efficacy of Ayurvedic management in PCOS: Study protocol for a randomized open-label standard control trial. Journal of Research in Ayurvedic Sciences, 8(3), 147-156..
5. Rotti, H., Mallya, S., Kabekkodu, S. P., Chakrabarty, S., Bhale, S., Bharadwaj, R.,... & Satyamoorthy, K. (2015). DNA methylation analysis of phenotype specific stratified Indian population. Journal of Translational Medicine, 13, 151. DOI: 10.1186/s12967-015-0506-0..
6. Aggarwal, S., Negi, S., Jha, P., Singh, P. K., Stobdan, T., Pasha, M. A., & Indian Genome Variation Consortium. (2010). EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proceedings of the National Academy of Sciences USA, 107(44), 18961–18966. DOI: 10.1073/pnas.1006108107..
7. Ghodke, Y., Joshi, K., & Patwardhan, B. (2011). Traditional medicine to modern pharmacogenomics: Ayurveda Prakriti type and CYP2C19 gene polymorphism associated with the metabolic variability. Evidence-Based Complementary and Alternative Medicine, 2011, 249528. DOI: 10.1093/ecam/nep206..
8. Govindaraj, P., Nizamuddin, S., Sharath, A., Jyothi, V., Rotti, H., Raval, R.,... & Thangaraj, K. (2015). Genome-wide analysis correlates Ayurveda Prakriti. Scientific Reports, 5, 15786. DOI: 10.1038/srep15786.
9. Patwardhan, B., Joshi, K., & Chopra, A. (2005). Classification of Human population based on HLA Gene Polymorphism and the Concept of Prakriti in Ayurveda. Journal of Alternative and Complementary Medicine, 11(2), 349–353. DOI: 10.1089/acm.2005.11.349..
10. Chen, Z. J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y.,... & NIH PCOS Workshop. (2011). Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nature Genetics, 43(1), 55-59. DOI: 10.1038/ng.732..
11. Khuraseva, A. B., & Svyatchenko, K. S. (2022). Genetic markers of polycystic ovary syndrome: Role in the pathogenesis and phenotypic manifestations of the disease. Medical Alphabet, (24), 44-47. DOI: 10.33667/2078-5631-2022-24-44-47..
12. Tewari, P. V. (Ed.). (2002). Kasyapa Samhita or Vridhajeevakatantram (Kalpa Sthana, Revathikalpadhyaya, Chapter 6, Shloka 33-34, pp. 357-358). Varanasi: Chaukhamba Viswabharathi..
13. Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D.,... & Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473. DOI: 10.7326/M18-0850..